UNSPSC 51334412: Pinoxepin

This classification denotes a dopamine antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y3YKO9X8N8. European Medicines Agency schedules Pinoxepin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09856MIG. Pinoxepin generally arises in the molecular formula C23H27CLN2O2.

UNSPSC 51334412 Pinoxepin, a Commodity code, covers pharmaceutical products and medical countermeasures state and local governments procure for emergency response and public health support. The recent activity under this code reflects procurement of naloxone (an opioid-overdose reversal agent) and associated drug-deactivation systems by county health departments to support community health and overdose-response initiatives. Issuing bodies include county-level public health and emergency management organizations conducting competitive bidding for pharmaceutical supplies and medical countermeasures.

Seminole County, Florida posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic bid submission, included E-Verify and drug-free workplace certification, and carried an initial two-year term with an option for one-year renewal; bidders were responsible for all shipping and delivery costs. The source contains no additional recent state or local opportunities under this code, and does not support characterization of geographic spread beyond the single Florida solicitation.